Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modafinil versus citalopram for major depressive disorder
IRCT20201026049152N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of modafinil and citalopram in major depressive disorder (MDD) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Treatment of major depression. Started Nov 2020; status: completed.
02
Drugs
modafinilcitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20201026049152N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201026049152N1.